Wednesday, 16 May 2012

[7] discussions, [3] comments and [1] job on LinkedIn

 
 
Medical Devices in Israel
 
LinkedIn
 
 
 
 
May 17, 2012
 

Latest: Discussions (7) Jobs (1) Members (40) Comments (3)

 
Still Active Discussions (1)
 
IP tip of the week: “If you love somebody, set them free…”
 
Started by Ariel Averbuch
 
you are so very right, Ariel' micki roll By micki roll
 
3 new comments
 
Discussions
 
IP tip of the week: “A friend of a friend is also your friend…”
 
Started by Ariel Averbuch, Head of the Pharma & BioTech Dept., Patent Attorney & Advocate at Dr.D.Graeser Ltd.
 
Like · Flag
 
פוסט חדש בבלוג| הסיכון הוא בהתעלמות ועוד 12 מילים| קריאה מהנה
 
Started by Uri Goren, Spokesman and PR Manager at Neopharm Group
 
Like · Flag
 
A mobile cardiac biomarker testing device could detect heart attacks faster
 
Started by Uri Goren, Spokesman and PR Manager at Neopharm Group
 
Like · Flag
 
התחזית שהתממשה: מניית פרוטליקס לא אטרקטיבית גם אם תאושר התרופה - כל הסיבות והניתוחים http://www.TheBiotechSite.co.il
 
Started by Nir Waysbort, Scientific Research Consultant and Professional
 
Like · Flag
 
Great speaker lineup at The Israel Conference!
 
Started by Paula Page, MEET AMAZING COMPANIES+THE LATEST TECHNOLOGY AT "THE ISRAEL CONFERENCE"....
 
Like · Flag
 
Do you know how to use #electronic #labeling for your #medicaldevices? Read all about the new #EU Regulation: http://bit.ly/IKKCS2
 
Started by Roxanna B., SEO Copywriter at Obelis s.a.
 
Like · Flag
 
סדנת יזמות במדעי החיים
 
Started by Tal Shprung, Biochemistry and Microbiology researcher at Weizmann Institute of Science
 
Like · Flag
 
Job Discussions (1)
 
Open Position: Image Processing Engineer
 
Posted by Michal Gabay, Biomedical Engineer
 
Like · Flag
 
 
 
 

Don't want to receive email notifications? Adjust your message settings.

Stop inappropriate content the moment it is posted. Send me an email for each new discussion »

LinkedIn values your privacy. At no time has LinkedIn made your email address available to any other LinkedIn user without your permission. © 2011, LinkedIn Corporation.

 
 
 
 

No comments:

Post a Comment